Literature DB >> 12139920

Ephrin-B1 promotes dendrite outgrowth on cerebellar granule neurons.

M Teresa Moreno-Flores1, Ester Martín-Aparicio, Jesús Avila, Javier Díaz-Nido, Francisco Wandosell.   

Abstract

Ephrins are developmentally regulated molecules that may contribute to axonal pathfinding through their binding to Eph receptor tyrosine kinases. In many cases, ephrins act as negative molecules that stimulate growth cone collapse, although some forms may promote axonal growth. Here, we have addressed the role played by ephrin-B1 during rat postnatal cerebellar development. Ephrin-B1 is expressed by both granule and Purkinje neurons whereas EphB is present in granule neurons in early postnatal cerebellum at a time coincident with axonal and dendrite outgrowth. Stably transfected 3T3 cells overexpressing ephrin-B1 enhance survival and neurite growth from cultured cerebellar granule neurons, an effect that is inhibited by the presence of an excess of a soluble EphB protein. Ephrin-B1-induced neuritogenesis is correlated with an increased expression of certain neuronal-specific microtubule-associated proteins (MAPs). Cerebellar granule neurons plated on stably transfected 3T3 cells overexpressing ephrin-B1 show an up-regulation of the expression of axonal MAPs such as Tau and phosphorylated MAP2C compared with neurons cultured on control 3T3 cells. The level of expression of these axonal MAPs is similar to that found in neurons plated on poly-L-lysine. Interestingly, there is a noteworthy up-regulation of somatodendritic MAPs such as high-molecular-weight MAP2 and mode II-phosphorylated MAP1B in neurons cultured on stably transfected 3T3 cells overexpressing ephrin-B1 compared with neurons plated on either control 3T3 cells or poly-L-lysine. In view of these data, we suggest that ephrin-B1 favors dendritogenesis of granule neurons during cerebellum development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12139920     DOI: 10.1006/mcne.2002.1128

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  6 in total

1.  Nuclear factor I coordinates multiple phases of cerebellar granule cell development via regulation of cell adhesion molecules.

Authors:  Wei Wang; Debra Mullikin-Kilpatrick; James E Crandall; Richard M Gronostajski; E David Litwack; Daniel L Kilpatrick
Journal:  J Neurosci       Date:  2007-06-06       Impact factor: 6.167

2.  The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway.

Authors:  Roy Barco; Laura B Hunt; Andrea L Frump; Christina B Garcia; Andrew Benesh; Robert L Caldwell; Josiane E Eid
Journal:  Mol Biol Cell       Date:  2007-08-08       Impact factor: 4.138

3.  The impact of CFNS-causing EFNB1 mutations on ephrin-B1 function.

Authors:  Roman Makarov; Bernhard Steiner; Zoran Gucev; Velibor Tasic; Peter Wieacker; Ilse Wieland
Journal:  BMC Med Genet       Date:  2010-06-17       Impact factor: 2.103

4.  Activity-dependent regulation of dendritic complexity by semaphorin 3A through Farp1.

Authors:  Lucas Cheadle; Thomas Biederer
Journal:  J Neurosci       Date:  2014-06-04       Impact factor: 6.167

5.  A sympathetic neuron autonomous role for Egr3-mediated gene regulation in dendrite morphogenesis and target tissue innervation.

Authors:  David H Quach; Michelle Oliveira-Fernandes; Katherine A Gruner; Warren G Tourtellotte
Journal:  J Neurosci       Date:  2013-03-06       Impact factor: 6.167

6.  Tubulin-related cerebellar dysplasia: definition of a distinct pattern of cerebellar malformation.

Authors:  Romina Romaniello; Filippo Arrigoni; Elena Panzeri; Andrea Poretti; Alessia Micalizzi; Andrea Citterio; Maria Francesca Bedeschi; Angela Berardinelli; Raffaella Cusmai; Stefano D'Arrigo; Alessandro Ferraris; Annette Hackenberg; Alma Kuechler; Margherita Mancardi; Sara Nuovo; Barbara Oehl-Jaschkowitz; Andrea Rossi; Sabrina Signorini; Frank Tüttelmann; Dagmar Wahl; Ute Hehr; Eugen Boltshauser; Maria Teresa Bassi; Enza Maria Valente; Renato Borgatti
Journal:  Eur Radiol       Date:  2017-07-04       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.